Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/07 01:05:46 pm
34.255 USD   +8.37%
05:42aNeedham Adjusts NeoGenomics' Price Target to $41 From $48; Buy Rating Kept
MT
11/30NEOGENOMICS : To Participate In The Stephens Annual Investment Conference 2021
PU
11/29INSIDER SELL : Neogenomics
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

NeoGenomics : Raymond James Upgrades NeoGenomics to Outperform from Market Perform, Sets $53 Price Target

10/14/2021 | 08:40am EST


ę MT Newswires 2021
All news about NEOGENOMICS, INC.
05:42aNeedham Adjusts NeoGenomics' Price Target to $41 From $48; Buy Rating Kept
MT
11/30NEOGENOMICS : To Participate In The Stephens Annual Investment Conference 2021
PU
11/29INSIDER SELL : Neogenomics
MT
11/10NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
11/10NeoGenomics, Inc. Appoints William Bonello as Chief Financial Officer, Effective Januar..
CI
11/10NeoGenomics, Inc. Appoints Kathryn Mckenzie as Chief Sustainability and Risk Officer, E..
CI
11/10NeoGenomics, Inc. Appoints Dave Daly to Its Board of Directors
CI
11/10NeoGenomics Appoints Dave Daly to Its Board of Directors
PU
11/08Morgan Stanley Cuts NeoGenomics to Equal-Weight From Overweight, Price Target to $45 Fr..
MT
11/08Genetron Holdings, NeoGenomics to Collaborate to Provide China-Based Medical Research S..
MT
More news
Analyst Recommendations on NEOGENOMICS, INC.
More recommendations
Financials (USD)
Sales 2021 485 M - -
Net income 2021 0,67 M - -
Net Debt 2021 288 M - -
P/E ratio 2021 -9 492x
Yield 2021 -
Capitalization 3 892 M 3 892 M -
EV / Sales 2021 8,62x
EV / Sales 2022 7,45x
Nbr of Employees 1 700
Free-Float 96,0%
Chart NEOGENOMICS, INC.
Duration : Period :
NeoGenomics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGENOMICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 31,61 $
Average target price 51,70 $
Spread / Average Target 63,6%
EPS Revisions
Managers and Directors
Mark Mallon Chief Executive Officer & Director
George A. Cardoza President & Chief Operating Officer-Lab Operations
Kathryn B. McKenzie Chief Financial Officer
Lynn A. Tetrault Non-Executive Chairman
Steven A. Ross Chief Information Officer & Vice President
Sector and Competitors